U.S. flag

An official website of the United States government

NM_033629.6(TREX1):c.598G>A (p.Asp200Asn) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 14, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002512754.5

Allele description [Variation Report for NM_033629.6(TREX1):c.598G>A (p.Asp200Asn)]

NM_033629.6(TREX1):c.598G>A (p.Asp200Asn)

Genes:
ATRIP:ATR interacting protein [Gene - OMIM - HGNC]
ATRIP-TREX1:ATRIP-TREX1 readthrough [Gene]
TREX1:three prime repair exonuclease 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p21.31
Genomic location:
Preferred name:
NM_033629.6(TREX1):c.598G>A (p.Asp200Asn)
HGVS:
  • NC_000003.12:g.48467253G>A
  • NG_009820.2:g.6424G>A
  • NG_033100.1:g.38608C>T
  • NG_033100.2:g.42557C>T
  • NG_041782.1:g.25544G>A
  • NG_099340.1:g.314G>A
  • NM_001271022.2:c.*1699G>A
  • NM_001271023.2:c.*1699G>A
  • NM_007248.5:c.568G>A
  • NM_032166.4:c.*1699G>A
  • NM_033629.6:c.598G>AMANE SELECT
  • NM_130384.3:c.*1699G>AMANE SELECT
  • NP_009179.2:p.Asp190Asn
  • NP_338599.1:p.Asp200Asn
  • NP_338599.1:p.Asp200Asn
  • LRG_282t1:c.598G>A
  • AAK07616.1:p.Asp200Asn
  • LRG_282:g.6424G>A
  • LRG_282p1:p.Asp200Asn
  • NC_000003.11:g.48508652G>A
  • NM_033629.4:c.598G>A
  • NR_153405.1:n.3907G>A
  • Q9NSU2:p.Asp255Asn
Protein change:
D190N; ASP200ASN
Links:
UniProtKB: Q9NSU2#VAR_032940; OMIM: 606609.0006; dbSNP: rs78846775
Molecular consequence:
  • NM_001271022.2:c.*1699G>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001271023.2:c.*1699G>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_032166.4:c.*1699G>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_130384.3:c.*1699G>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_007248.5:c.568G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033629.6:c.598G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_153405.1:n.3907G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Aicardi-Goutieres syndrome 1
Synonyms:
CREE ENCEPHALITIS; ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATION AND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS; PSEUDOTOXOPLASMOSIS SYNDROME
Identifiers:
MONDO: MONDO:0009165; MedGen: C0796126; Orphanet: 51; OMIM: 225750
Name:
Chilblain lupus 1 (CHBL1)
Identifiers:
MONDO: MONDO:0012500; MedGen: C0024145; OMIM: 610448
Name:
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCLS)
Synonyms:
CEREBRORETINAL VASCULOPATHY, HEREDITARY; RETINOPATHY, VASCULAR, WITH CEREBRAL AND RENAL INVOLVEMENT AND RAYNAUD AND MIGRAINE PHENOMENA
Identifiers:
MONDO: MONDO:0008641; MedGen: C1860518; Orphanet: 3421; Orphanet: 63261; Orphanet: 71291; OMIM: 192315

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003525218Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Mar 14, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome.

Rice G, Newman WG, Dean J, Patrick T, Parmar R, Flintoff K, Robins P, Harvey S, Hollis T, O'Hara A, Herrick AL, Bowden AP, Perrino FW, Lindahl T, Barnes DE, Crow YJ.

Am J Hum Genet. 2007 Apr;80(4):811-5. Epub 2007 Feb 19.

PubMed [citation]
PMID:
17357087
PMCID:
PMC1852703

Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome.

Ramantani G, Kohlhase J, Hertzberg C, Innes AM, Engel K, Hunger S, Borozdin W, Mah JK, Ungerath K, Walkenhorst H, Richardt HH, Buckard J, Bevot A, Siegel C, von Stülpnagel C, Ikonomidou C, Thomas K, Proud V, Niemann F, Wieczorek D, Häusler M, Niggemann P, et al.

Arthritis Rheum. 2010 May;62(5):1469-77. doi: 10.1002/art.27367.

PubMed [citation]
PMID:
20131292
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003525218.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 200 of the TREX1 protein (p.Asp200Asn). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Aicardi-Goutieres syndrome (PMID: 17357087, 20131292). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 4184). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects TREX1 function (PMID: 18805785). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 6, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search